Clinical Topics and Safe Driving
Alzheimer’s disease is due to a degenerative process, associated with significant neuronal loss in multiple brain areas, and marked brain atrophy.
Dementia is a clinical syndrome characterized by the acquired loss of cognitive capacities. For more information about dementia visit Fundación MAPFRE.
Syncope can be defined as the sharp loss of consciousness due to a sudden brain blood flow reduction or to changes in the chemical composition of blood.
For the possibility of a significant glucose reduction in the CNS, the activity of the upper cerebral centers declines to reduce the brain needs for energy.
Syncopes of respiratory, water-electrolyte, somatization or pharmacological origin and their influence in driving
The decompensation of chronic bronchopneumopathies with emphysema is the most common cause of respiratory encephalopathy. More at Fundación MAPFRE.
Every drug administration involves the risk of causing an adverse reaction. Patients cannot recognize the side effects of the new drug they start to take.
Over the counter drugs are increasingly is dispensed as indicated by non-qualified subjects, who many times do not know the diseases and their treatment.
The driver should take in a visible place inside the car the medical report specifying his disease and its treatment. More details at Fundación MAPFRE.
The epileptic driver has a potential risk of accident, for the possibility of loss of consciousness and for the side effects of the medication.
The antiarrhythmic medication plays a major role in most significant arrhythmias, all these drugs have limitations. More details at Fundación MAPFRE site.
Learn more about the effects of anti-asthma medications and oral blood thinners. For more details about road safety tips and doctors tips visit Fundación MAPFRE.
Knows the effects on the conduction of Digestive Pathology Drugs such as: H2 drugs, antiacids and antagonists. For more information visit Fundación MAPFRE.